Tianjin established a new joint venture company with a capital of 680 million yuan, including Tongrentang Health Pharmaceuticals.

According to the Tianyancha App, recently, Tianjin Lisimingxingjing Entrepreneurial Investment Partnership Enterprise was established, with Tianjin Lisiming Mingtang Enterprise Management Consulting Partnership Enterprise as the executing partner. The registered capital is 680 million RMB, and the business scope includes entrepreneurial investments and investment activities with its own funds. The partner information shows that the partnership enterprise is jointly invested by Tongrentang, Ningbo Purun Investment Partnership Enterprise, Shanghai Zhongyuan Second-phase Private Equity Fund, and Nanjing Huatai Yanghe Equity Investment Fund.